The Impact of Exercise on the Tumor Microenvironment in Patients With Lung Cancer
University of Arizona · NCT07216209
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 48
- US sites recruiting
- 1
- Study start
- January 13, 2026
- Record last updated
- April 21, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
There is increased interest and knowledge about the lung cancer tumor microenvironment (TME). Investigators hypothesize that patients with better baseline physiologic health will have better post-operative outcomes and that strenuous exercise will alter the TME and genetic make-up of the tumor, improving the tumor immune response. Investigators aim to identify the peri-operative and clinical outcomes that differ based on pre-operative VO2max, HRV and resting heart rate following resection of early-stage lung cancer. The physiologic states that are individual and measurable with wearable devices include but are not limited to VO2max, heart rate variability (HRV), and average resting heart rate. Investgators hypothesize that a patient's pre-operative physiologic function with higher VO2max, HRV and lower resting heart rate will be associated with improved peri-operative and post-operative outcomes. Second, investigators will compare alterations in TME based on targeted pre-operative exercise (60-80% of their VO2 max for 75min/week x2 weeks) compared to normal activity adults following resection of early-stage lung cancer. Investigators hypothesize that strenuous exercise in the pre-operative period will impact the TME by increasing levels of cytokines.
Being studied: EXERCISE TRAINING WITH OR WITHOUT MEDICATION
Conditions: Lung Cancer - Non Small Cell
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- lung cancer
- low risk for submaximal exercise testing in accordance with the risk stratification guidelines published by the American Heart Association and the American College of Sports Medicine (AHA/ACSM criteria).
Exclusion Criteria
- younger than 18 years of age
- select a condition on the ACSM-AHA pre-exercise screening questionnaire indicating that physician approval is required prior to exercise
- body mass index of >30 kg/m2
- waist girth of >102cm for men and >88cm for women
- have chronic/debilitating arthritis
- have been bedridden in the past three months
- have common illness (i.e. colds) within the past 6-weeks
- HIV
- hepatitis
- history of stroke
- major affective disorder
- autoimmune disease
- pregnancy or are breast-feeding
- history of severe anaphylactic reaction to an allergen
- present with more than one of the following CVD risk factors: family history of myocardial infarction, coronary revascularization, or sudden death before 55 years of age in father or other male first-degree relative or before 65 years of age in mother or other female first-degree relative
Recruiting US locations
University of Arizona Cancer Center
Tucson, AZ 85719
Site contact: Stephanie Worrell, MD · 520-626-7806 · sworrell@arizona.edu
Study contacts (from the official record)
- Stephanie Worrell, MD · 5206267806 · sworrell@arizona.edu
- Melissa Landau · 5206267806 · mlandau@surgery.arizona.edu
Similar studies in Arizona
All healthy volunteers studies in Arizona →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Developing Biomarkers of Dietary Intake: Dose Dependent Measurement of Sugar Intake
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Location
- Phoenix, AZ
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234
AstraZeneca
- Location
- Chandler, AZ + 2 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingHealthy volunteersPhase 1
A Phase 1 Relative Bioavailability Study of a VX-581 Tablet Formulation
Vertex Pharmaceuticals Incorporated
- Location
- Tempe, AZ
- Eligibility basics
- Ages 18–55 · Men only
- RecruitingHealthy volunteersPhase 1
A Single and Multiple Ascending Dose Study of EPX-100 in Healthy Adult Participants
Epygenix
- Location
- Tempe, AZ
- Eligibility basics
- Ages 18–55